Dog Longevity Startup Loyal Secures $45 Million in Funding
Wall Street Journal
Biotech startup Loyal has raised $45 million in equity to help bring its first longevity drug for dogs to market.
https://www.wsj.com/articles/dog-longevity-startup-loyal-secures-45-million-in-funding-23d85cf1